Medical Community Renames PCOS to Reflect Broader Understanding of Condition
The medical community has officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). This change comes after 14 years of collaboration between researchers and patients, aiming to better reflect the condition's nature as a whole-body hormonal and metabolic disorder rather than one primarily defined by ovarian cysts. The renaming process highlights the evolving understanding of the condition and the importance of patient perspectives in medical nomenclature. Dr. Richard Barnett, a historian of medicine, notes that disease names often change as scientific knowledge and patient perspectives evolve. The decision to rename PCOS is part of a broader trend in medical history where disease names are updated to reduce stigma and improve accuracy, as seen with the renaming of monkeypox to mpox. 
